You searched for "sustainable"
Modifying two-week wait protocol for suspected head and neck cancer patients during COVID-19
As healthcare workers, we are committed to ensuring that our patients continue to receive the optimum care that we are set up to deliver. However, the last year has shown that we need to be mindful of balancing this with...Screening: evaluating the outcomes of early intervention
Newborn hearing screening is now the accepted standard of care in several countries, and is becoming increasingly more established worldwide. White [1] reported eight countries screening over 90% of newborns, ten screening between 25-89% of births and a further 54...Current management of unilateral sporadic vestibular schwannoma
Vestibular schwannoma is the commonest tumour of the cerebellopontine angle (80%) and accounts for around 8% of all intracranial tumours. The commonest primary presenting symptoms are audio vestibular. Hearing health professionals are often the first contact for patients with potential symptoms of vestibular schwannoma, with the majority then being seen and diagnosed by otorhinolaryngologists.Mindfulness and tinnitus: a path to peace in the present
How does training the mind to be present in the here and now help patients with troublesome tinnitus? James Jackson discusses mindfulness and its place in tinnitus management. Although definitions can be more complex, tinnitus is the perception of sound...
Patients with severe uncontrolled CRSwNP respond to biologics in the real world
Clinical trials have demonstrated that biologics are effective in treating patients with chronic rhinosinusitis with nasal polyps (CRSwNP). This multicentre (15 tertiary care centres in France) observational prospective cohort study aims to examine the effectiveness of biologics in treating CRSwNP...Neuromod launches Lenire tinnitus treatment device to tinnitus sufferers in the UK
Neuromod Devices has launched its Lenire tinnitus treatment device in the United Kingdom, where it is estimated that seven million people suffer from tinnitus.Neuromod publishes results of second large-scale clinical trial for tinnitus, shows greater improvement of symptoms
Neuromod Devices, the medical device company specialising in tinnitus, has published the results of its TENT-A2 (Treatment Evaluation of Neuromodulation for Tinnitus – Stage A2) clinical trial in the scientific journal, Nature – Scientific Reports in a paper titled ‘Different bimodal neuromodulation settings reduce tinnitus symptoms in a large randomized trial’.Enhancing surgical outcomes in TOETVA – with neuromonitoring essentials by Langer Medical
Intraoperative neuromonitoring has become a standard practice in all thyroid surgery, allowing for the precise localisation and reliable monitoring of neurophysiological structures at-risk.
